Viromed Medical
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
VMED | DU
Overview
Corporate Details
- ISIN(s):
- DE000A3MQR65
- LEI:
- 894500XR05MYCVCCR171
- Country:
- Germany
- Address:
- Flensburger Straße 18, 25421 Pinneberg
- Website:
- https://www.viromed.de/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Viromed Medical is a medical technology company specializing in solutions to protect people from infection. Since its founding in 2004, the company has focused on research into viruses and bacteria, leading to the development of holistic solutions centered on its pioneering cold atmospheric plasma (CAP) technology. Its key applications include air disinfection, wound healing, and intensive care medicine. Viromed develops and distributes its medical devices to a network of hospitals, nursing homes, and medical practices. The company also provides digital connectivity solutions to streamline processes and treatments for healthcare stakeholders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-27 17:30 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, sell
|
English | 6.1 KB | ||
| 2025-10-24 17:30 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, sell
|
English | 6.1 KB | ||
| 2025-10-21 19:10 |
Major Shareholding Notification
Viromed Medical AG: Reallocation of Viromed shares broadens investor base
|
English | 7.6 KB | ||
| 2025-10-21 18:02 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, sell
|
English | 6.1 KB | ||
| 2025-10-16 17:04 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, sell
|
English | 6.1 KB | ||
| 2025-10-14 10:17 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, sell
|
English | 6.0 KB | ||
| 2025-10-08 16:30 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, buy
|
English | 6.0 KB | ||
| 2025-10-07 14:01 |
Director's Dealing
Viromed Medical AG: Uwe Perbandt, buy
|
English | 5.9 KB | ||
| 2025-10-01 09:33 |
Earnings Release
Viromed Medical AG drives forward market launch of new products in the first ha…
|
English | 8.2 KB | ||
| 2025-09-30 11:47 |
Regulatory News Service
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on livin…
|
English | 7.4 KB | ||
| 2025-09-23 11:08 |
Regulatory News Service
Viromed Medical AG initiates approval process for PulmoPlas with the Federal In…
|
English | 7.7 KB | ||
| 2025-09-18 10:23 |
Regulatory News Service
Viromed Medical AG: Successful ISO 13485 certification paves the way for market…
|
English | 8.0 KB | ||
| 2025-07-29 14:08 |
Post-Annual General Meeting Information
Viromed Medical AG: Annual General Meeting approves all proposed resolutions by…
|
English | 8.9 KB | ||
| 2025-07-24 09:30 |
Regulatory News Service
Viromed Medical AG enters into a distribution partnership with TriPart for the …
|
English | 7.6 KB | ||
| 2025-06-30 15:36 |
Earnings Release
Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2…
|
English | 6.7 KB |
Automate Your Workflow. Get a real-time feed of all Viromed Medical filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Viromed Medical
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Viromed Medical via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
